BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27261568)

  • 1. The Risk of Cancer With the Use of Recombinant Human Bone Morphogenetic Protein in Spine Fusion.
    Dettori JR; Chapman JR; DeVine JG; McGuire RA; Norvell DC; Weiss NS
    Spine (Phila Pa 1976); 2016 Aug; 41(16):1317-1324. PubMed ID: 27261568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer follow-up continues to reveal no increased risk of cancer with the use of recombinant human bone morphogenetic protein in spine fusion.
    Dettori JR; Chapman JR; DeVine JG; McGuire RA; Junge MR; Norvell DC
    Spine J; 2019 Oct; 19(10):1640-1647. PubMed ID: 31108234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer.
    Sayama C; Willsey M; Chintagumpala M; Brayton A; Briceño V; Ryan SL; Luerssen TG; Hwang SW; Jea A
    J Neurosurg Pediatr; 2015 Jul; 16(1):4-13. PubMed ID: 25860984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Morphogenetic Proteins in Spinal Surgery: What Is the Fusion Rate and Do They Cause Cancer?
    Malham GM; Giles GG; Milne RL; Blecher CM; Brazenor GA
    Spine (Phila Pa 1976); 2015 Nov; 40(22):1737-42. PubMed ID: 26730525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
    Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.
    Carragee EJ; Chu G; Rohatgi R; Hurwitz EL; Weiner BK; Yoon ST; Comer G; Kopjar B
    J Bone Joint Surg Am; 2013 Sep; 95(17):1537-45. PubMed ID: 24005193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
    Villavicencio AT; Burneikiene S
    Spine J; 2016 Oct; 16(10):1208-1213. PubMed ID: 27343729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
    Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cancer after lumbar fusion surgery with recombinant human bone morphogenic protein-2 (rh-BMP-2).
    Cooper GS; Kou TD
    Spine (Phila Pa 1976); 2013 Oct; 38(21):1862-8. PubMed ID: 23883824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.
    Fu R; Selph S; McDonagh M; Peterson K; Tiwari A; Chou R; Helfand M
    Ann Intern Med; 2013 Jun; 158(12):890-902. PubMed ID: 23778906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
    Burkus JK; Dryer RF; Peloza JH
    J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 24-month retrospective update: follow-up hospitalization charges and readmissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2).
    Wetzell B; McLean JB; Dorsch K; Moore MA
    J Orthop Surg Res; 2021 Nov; 16(1):680. PubMed ID: 34794470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.
    Faundez A; Tournier C; Garcia M; Aunoble S; Le Huec JC
    Int Orthop; 2016 Jun; 40(6):1309-19. PubMed ID: 26961193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography.
    Sayama C; Hadley C; Monaco GN; Sen A; Brayton A; Briceño V; Tran BH; Ryan SL; Luerssen TG; Fulkerson D; Jea A
    J Neurosurg Pediatr; 2015 Jul; 16(1):14-20. PubMed ID: 25860982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urological complications following use of recombinant human bone morphogenetic protein-2 in anterior lumbar interbody fusion: presented at the 2012 Joint Spine Section Meeting: clinical article.
    Lubelski D; Abdullah KG; Nowacki AS; Alvin MD; Steinmetz MP; Chakka S; Li Y; Gajewski N; Benzel EC; Mroz TE
    J Neurosurg Spine; 2013 Feb; 18(2):126-31. PubMed ID: 23231356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
    Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
    J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?
    Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA
    Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
    Lee DD; Kim JY
    J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.